Cover Image
市場調查報告書

全球癌症幹細胞市場:技術和全球市場

Cancer Stem Cells: Technologies and Global Markets

出版商 BCC Research 商品編碼 598094
出版日期 內容資訊 英文 180 Pages
訂單完成後即時交付
價格
Back to Top
全球癌症幹細胞市場:技術和全球市場 Cancer Stem Cells: Technologies and Global Markets
出版日期: 2017年12月29日 內容資訊: 英文 180 Pages
簡介

全球癌症幹細胞市場預測將從2017年的7億4,500萬美元以年複合成長率21.2%擴大,到2022年前達到19億美元的規模。

本報告提供全球癌症幹細胞市場相關調查,彙整市場概要和到2022年的成長預測,各類型,各地區趨勢,競爭環境,及加入此市場的主要企業的簡介等資料。

第1章 簡介

第2章 摘要和亮點

第3章 市場與技術概要

  • 市場定義和範圍
  • 癌症幹細胞的歷史
  • 合成,隔離,鑑定
  • 癌症幹細胞的特性
    • 癌細胞的轉移
    • 細胞凋亡
    • 對化療的抗性
  • 幹細胞的分類
    • 分化能力
    • 來源
  • 作用機制
    • 信號途徑
    • 癌症幹細胞標記
    • miRNA表現
    • 癌症幹細胞利基
  • 幹細胞移植
  • 癌症幹細胞臨床實驗平台
  • 市場趨勢

第4章 癌症類別市場

  • 肺癌
  • 乳癌
  • 大腸癌
  • 白血病
  • 黑色素瘤
  • 前列腺癌
  • 腦瘤
  • 骨癌

第5章 各地區市場

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 專利檢討

第7章 企業簡介

附錄:專利清單

BCC 關於Research

目錄
Product Code: BIO158A

Report Highlights

The global market for cancer stem cells will grow from $745 million in 2017 to $1.9 billion by 2022 with a compound annual growth rate (CAGR) of 21.2% for the period of 2017-2022.

Report Includes:

  • 27 data tables and 25 additional tables
  • An overview of the global market for cancer stem cells and related technologies
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Segmentation of the market by type and by region
  • Discussion of market dynamics, including drivers, restraints, and opportunities
  • Insight into the competitive landscape, including strategies, acquisitions, agreements, and new product launches
  • Profiles of suppliers of cancer stem cells and analyses based on market share, cancer type, and region

Report Scope

This research report presents an in-depth analysis of the global cancer stem cells market by cancer type and geographic markets. The report includes key inhibitors that affect various factors that help in growth of cancer stem cells. The report discusses the role of supply chain members from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global cancer stem cells market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe, and China.

The cancer stem cells market is mainly segmented into two major components: cancer type and geography. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, prostate cancer, brain cancer, bone cancer, and other types of cancer. The market is segmented by geography into the North America, Europe, Asia-Pacific, and ROW.MBA in marketing.

Analyst Credentials

Sangeeta Rai is a senior researcher who has analyzed and forecasted healthcare and advanced chemicals markets since 2011. She holds a Bachelor of Science in biotechnology and a Master of Business Administration in marketing. Prior to joining BCC Research, she has held senior research roles at Global Data and Infinity Research. Sangeeta Rai is a pseudonym of the author.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Market Definition and Scope
  • History of Cancer Stem Cells
  • Synthesis, Isolation and Identification of CSCs
  • Characteristics of Cancer Stem Cells
    • Metastasizing Tumor Cells
    • Apoptosis
    • Resistance to Chemotherapy
  • Stem Cell Classification
    • Based on Ability to Differentiate
    • Based on Source
  • Mechanism of Action
    • Targeting Signaling Pathways
    • Targeting CSCs Markers
    • Targeting miRNA Expression
    • Targeting CSCs' Niche
  • Stem Cell Transplants
    • Autologous
    • Allogeneic
    • Syngeneic
  • Cancer Stem Cell Clinical Pipeline
  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity

Chapter 4: Market Breakdown by Cancer Type

  • Lung Cancer
    • Incidence of Lung Cancer
    • Risk Factors
    • Types of Lung Cancer
    • Site of Lung Tumor Initiation
    • Lung Cancer Stem Cells as Therapeutic Targets
  • Breast Cancer
    • Incidence and Mortality Rate of Breast Cancer
    • Types of Breast Cancer
    • Site of Tumor Initiation
    • Breast Cancer Stem Cells as Therapeutic Targets
  • Colorectal Cancer
    • Incidence and Mortality of Colorectal Cancer
    • Colorectal Cancer Stem Cells as Therapeutic Targets
  • Leukemia
    • Incidence and Mortality of Leukemia
    • Leukemia Stem Cells as Therapeutic Targets
  • Melanoma
    • Incidence and Mortality of Melanoma
    • Melanoma Cancer Stem Cells as Therapeutic Targets
  • Prostate Cancer
    • Incidence and Mortality Rate of Prostate Cancer
    • Prostate Cancer Stem Cells as Therapeutic Targets
  • Brain Cancer
    • Incidence of Brain Cancer
    • Brain Cancer Stem Cells as Therapeutic Targets
  • Bone Cancer
    • Bone Cancer Stem Cells as Therapeutic Targets
    • Others

Chapter 5: Market Breakdown by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • ROW
    • Brazil
    • Saudi Arabia
    • Other Countries

Chapter 6: Patent Review

  • Patent Analysis
    • Patent Review by Year
    • Patent Review by Region
    • Patent Review by Assignee

Chapter 7: Company Profiles

Appendix: List of Patents

  • List of Patents North America
  • List of Patents Europe
  • List of Patents Asia-Pacific
  • List of Patents ROW

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table: Global Cancer Stem Cells Market, by Cancer Type, Through 2022 ($ Millions)
    • Table 1 Clinical Trials of Cancer Stem Cells, by NCT Number
    • Table 2 Global Cancer Stem Cells Market, by Cancer Type, Through 2022 ($ Millions)
    • Table 3 Global Cancer Stem Cells Market for Lung Cancer, by Region, Through 2022 ($ Millions)
    • Table 4 Global Cancer Stem Cells Market for Breast Cancer, by Region, Through 2022 ($ Millions)
    • Table 5 Global Cancer Stem Cells Market for Colorectal Cancer, by Region, Through 2022 ($ Millions)
    • Table 6 Global Cancer Stem Cells Market for Leukemia, by Region, Through 2022 ($ Millions)
    • Table 7 Global Cancer Stem Cells Market for Melanoma, by Region, Through 2022 ($ Millions)
    • Table 8 Global Cancer Stem Cells Market for Prostate Cancer, by Region, Through 2022 ($ Millions)
    • Table 9 Global Cancer Stem Cells Market for Brain Cancer, by Region, Through 2022 ($ Millions)
    • Table 10 Global Cancer Stem Cells Market for Bone Cancer, by Region, Through 2022 ($ Millions)
    • Table 11 Global Cancer Stem Cells Market for Other Types of Cancer, by Region, Through 2022 ($ Millions)
    • Table 12 Global Market for Cancer Stem Cells, by Region, Through 2022 ($ Millions)
    • Table 13 North American Cancer Stem Cells Market, by Country, Through 2022 ($ Millions)
    • Table 14 North American Market for Cancer Stem Cells, by Cancer Type, Through 2022 ($ Millions)
    • Table 15 European Market for Cancer Stem Cells, by Country, Through 2022 ($ Millions)
    • Table 16 European Market for Cancer Stem Cells, by Cancer Type, Through 2022 ($ Millions)
    • Table 17 Asia-Pacific Market for Cancer Stem Cells, by Country, Through 2022 ($ Millions)
    • Table 18 Asia-Pacific Market for Cancer Stem Cells, by Cancer Type, Through 2022 ($ Millions)
    • Table 19 RoW Market for Cancer Stem Cells, by Country, Through 2022 ($ Millions)
    • Table 20 RoW Market for Cancer Stem Cells, by Cancer Type, Through 2022 ($ Millions)
    • Table 21 Patent Share for Global Cancer Stem Cells, by Year, 2011-2016 (No./%)
    • Table 22 Patent Share in the Global Cancer Stem Cell Market, by Region (No./%)
    • Table 23 Patent Share in the Global Cancer Stem Cell Market, by Country (No./%)
    • Table 24 Patent Share in the Global Cancer Stem Cell Market, by Assignee (No./%)
    • Table 25 Product Portfolio: Adnagen
    • Table 26 Product Portfolio: Advanced Cell Diagnostics
    • Table 27 Product Portfolio: Apceth Biopharma
    • Table 28 Product Portfolio: Avia Biosciences
    • Table 29 Product Portfolio: Benitec Biopharma
    • Table 30 Product Portfolio: Caladrius Biosciences
    • Table 31 Product Portfolio: Celgene Corp
    • Table 32 Product Portfolio: Commence Bio
    • Table 33 Product Portfolio: Epic Sciences
    • Table 34 Product Portfolio: ExCellThera
    • Table 35 Product Portfolio: Fluxion Biosciences
    • Table 36 Product Portfolio: Galena Biopharma
    • Table 37 Galena Biopharma Inc., Financial Results, 2014-2016 ($ Millions)
    • Table 38 Product Portfolio: Gamida Cell
    • Table 39 Product Portfolio: Genexine
    • Table 40 Product Portfolio: Geron
    • Table 41 Product Portfolio: ImmunoCellular Therapeutics
    • Table 42 Product Portfolio: Novartis
    • Table 43 Product Portfolio: OncoCyte
    • Table 44 Product Portfolio: OncoMed
    • Table 45 Product Portfolio: Pluristem Therapeutics
    • Table 46 Product Portfolio: Rarecells USA
    • Table 47 Product Portfolio: Silicon Biosystems
    • Table 48 Product Portfolio: Sphere Fluidics
    • Table 49 Product Portfolio: Vitatex
    • Table 50 List of Patents North America
    • Table 51 List of Patents Europe
    • Table 52 List of Patents Asia-Pacific
    • Table 53 List of Patents ROW

List of Figures

  • Summary Figure: Global Cancer Stem Cells Market, by Cancer Type, 2016-2022 ($ Millions)
    • Figure 1 Classification of Stem Cells Based on Source
    • Figure 2 Number of New Cancer Cases and Mortality Rates Worldwide, 2012
    • Figure 3 Global Segmentation for Cancer Stem Cells Market
    • Figure 4 Incidence of Lung Cancer, 2012 (Thousands)
    • Figure 5 Incidence and Mortality of Breast Cancer among More and Less Developed Regions, 2012 (Thousands)
    • Figure 6 Incidence and Mortality of Breast Cancer among Different Geographic Regions, 2012 (Thousands)
    • Figure 7 Incidence and Mortality of Colorectal Cancer among More and Less Developed Regions, 2012 (Thousands)
    • Figure 8 Incidence and Mortality of Colorectal Cancer among Different Geographic Regions, 2012 (Thousands)
    • Figure 9 Incidence and Mortality Rates of Leukemia in U.S., 2010-2014 (Rates are per 100,000)
    • Figure 10 Incidence and Mortality Rates of Melanoma in U.S., 2010-2014 (Rates are per 100,000)
    • Figure 11 Increase in Incidence of Cancer in North America, 2009-2013 (per 100,000 Population)
    • Figure 12 Number of New Cases and Deaths due to Cancer in U.S., 2017
    • Figure 13 U.S. Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 14 Number of New Cases and Deaths due to Cancer in Canada, 2017
    • Figure 15 Canada Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 16 Cancer Incidence and Mortality in Mexico, 2012
    • Figure 17 Mexico Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 18 Cancer Incidence and Mortality in Europe, 2012 (Thousands)
    • Figure 19 Cancer Incidence and Mortality in Germany, 2012
    • Figure 20 Germany Cancer Stem Cells Market, 2016-2022 ($ Millions
    • Figure 21 Cancer Incidence and Mortality in France, 2012
    • Figure 22 France Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 23 Cancer Incidence and Mortality in the United Kingdom, 2014
    • Figure 24 U.K. Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 25 Rest of Europe Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 26 Top Five Countries in the Highest Number of Cancer Cases in Asia, 2012 (%)
    • Figure 27 Cancer Incidence and Mortality in Southeast Asia, 2012
    • Figure 28 Cancer Incidence in Japan, by Cancer Type, 2015
    • Figure 29 Cancer Deaths in Japan, by Cancer Type, 2015
    • Figure 30 Budget to Control Cancer in Japan, 2003-2015 (100 Million Yen)
    • Figure 31 Japanese Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 32 Cancer Incidence and Mortality in China, 2012
    • Figure 33 Chinese Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 34 Cancer Incidence and Mortality in Australia, 2012
    • Figure 35 Australian Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 36 Cancer Incidence and Mortality in India, 2012
    • Figure 37 Indian Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 38 Rest of Asia-Pacific Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 39 Estimated Percentage of New Cancer Cases by Cancer Type in Latin America and the Caribbean, 2012 (%)
    • Figure 40 Estimated Percentage of Cancer Deaths by Cancer Type in Latin America and the Caribbean, 2012
    • Figure 41 Cancer Incidence and Mortality in Brazil, 2012
    • Figure 42 Brazil Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 43 Most Common Cancer Cases in Saudi Arabia, by Gender, 2013
    • Figure 44 Cancer Incidence and Mortality in Saudi Arabia, 2012
    • Figure 45 Saudi Arabia Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 46 Other Countries Cancer Stem Cells Market, 2016-2022 ($ Millions)
    • Figure 47 Patent Share for Global Cancer Stem Cells, by Year, 2011-2016 (%)
    • Figure 48 Patent Share in the Global Cancer Stem Cell Market, by Region (%)
    • Figure 49 Patent Share in the Global Cancer Stem Cell Market, by Country (%)
    • Figure 50 Patent Share in the Global Cancer Stem Cell Market, by Assignee (%)
Back to Top